Novel drug may provide hope to Alzheimer's patients
Researchers at Tohoku University (Sendai, Japan) have recently developed a novel drug, termed SAK3, which could potentially lead to the development of the first disease-modifying drug to prevent mild to severe Alzheimer disease.
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet – the medicinal chemistry network
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.